FDA.reportPublic FDA data

NDC 65219-610 - Adalimumab-aacf

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
65219-610
Package NDCs from labels
65219-610-02
Manufacturer
Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA
Effective date
2026-01-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
adalimumab - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPAFresenius Kabi USA, LLC | Fresenius Kabi Austria | Merck Serono SPA2026-01-08HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65219-610-02Adalimumab-aacf0.8 mL in 1 SYRINGE, GLASSINJECTION, SOLUTION1.6 mL40 mg in 0.8mL6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65219-610ADALIMUMAB-AACF (ADALIMUMAB) KIT [FRESENIUS KABI USA, LLC]5Unmatched20240826_2488b0bc-7b8f-4cc8-91ea-48e7ea5e8915.zip